RTW Biotech Opportunities Ltd




Closed End Funds

Market Closed - London S.E. 11:35:14 2024-06-14 am EDT 5-day change 1st Jan Change
1.6 USD +8.11% Intraday chart for RTW Biotech Opportunities Ltd +12.68% +14.08%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Christie trading improved, maintains expectations AN
RTW Biotech portfolio company to sell subsidiary for USD1.25 billion AN
RTW Biotech Opportunities Ltd commences an Equity Buyback Plan for 57,844,388 shares, representing 14.99% of its issued share capital, under the authorization approved on May 16, 2024. CI
RTW Biotech Opportunities Ltd?s Equity Buyback announced on July 20, 2023, has expired. CI
Future Metals celebrates state government grant AN
RTW Biotech Opportunities Invests in Lycia Therapeutics $106 Million Funding Round MT
RTW Biotech invests in cell and gene therapy company Obsidian AN
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises AN
RTW Biotech Opportunities Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Franchise Brands sets targets, Cindrigo agrees loan AN
RTW Biotech Opportunities NAV increases 2.5% in January AN
RTW Biotech Opportunities Completes Arix Bioscience Acquisition MT
Katoro Gold launches fundraising, eyes board shake-up AN
Arix Bioscience's Asset Sale to RTW Biotech Takes Effect MT
Arix Bioscience shares suspended ahead of RTW takeover AN
Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition MT
Apax opts against lifting offer; DCI enters loan deal AN
Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech MT
Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech MT
RTW Biotech completes Arix investment in takeover run-up AN
RTW Biotech Buys Minority Stake in Arix Bioscience to Support Planned Takeover MT
RTW Biotech's manager invests USD127 million in Ji Xing AN
RTW Biotech Opportunities invests USD127 million in investee Ji Xing AN
Microsaic in funding talks; Jarvis says no payout AN
FTSE 100 Closes Up 0.28% as Interest Rate Rise Fears Start to Ease DJ
Chart RTW Biotech Opportunities Ltd
More charts
RTW Biotech Opportunities Ltd is a Guernsey-based focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.
More about the company
  1. Stock Market
  2. Equities
  3. RTWG Stock
  4. News RTW Biotech Opportunities Ltd
  5. RTW Biotech Opportunities Invests in Lycia Therapeutics $106 Million Funding Round